KRIBIOLISA™ Mirzotamab ELISA

SKU: KBI1470 Category:

58,000.00

Enzyme Immunoassay for the estimation of Mirzotamab in serum and plasma.

About the kit:
– Uses anti-idiotypic monoclonal antibodies which ensures higher specificity, and low cross reactivity.
– Recovery rates are between 85 – 115%
– Validated as per US FDA guidelines for Bioassays
– Precision CV<10%

Availability: 3 – 4 Weeks | Pack Size: 1 x 96 wells



Description

Background:
Mirzotamab is an IgG1 antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclaxum, an BCL2L1 inhibitor to form Mirzotamab clezutoclax , involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax is a targeted antibody drug conjugate (ADC).

Intended Use:
For Estimation of Mirzotamab in human serum and plasma. Please note the kit has not been optimized to be used for any other animal species. Should you require a specific sera tested, please connect with us at sales@krishgen.com for optimization.

If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!

View more details about our Publication Reward

Additional information

Cross Reactivity

< 0.5% cross-reactivity observed with related biomarker.

Interference

No significant interference observed with available related molecules.

Regulatory Status

Research Use Only

Research Area

Biosimilars / Therapeutic Drug Monitoring

ELISA Type

Direct Sandwich Assay

Storage Temperature

Store the unopened product at 2-8 Degree Celcius. Concentrated detection conjugate should be stored at -20 Degree Celcius. Do not use past expiration date.

Shipping Temperature

2-8 Degree Celcius. Concentrated detection conjugate ship at -20 Degree Celcius in a second box. Freight applicable for both.